Newsletter | September 22, 2022

09.22.22 -- A CTO's Journey Into Continuous Biomanufacturing

Featured Editorial
Industry Insights
Quality Matters: SEC Analysis For Antibody Aggregates

Size exclusion chromatography is the go-to analytical method for therapeutic protein drugs. This article describes the factors affecting the reproducibility of columns and how you can minimize column variation.

Three Reasons Integrated CDMO Models Are Best

Some of pharma’s top brands developed their own responses to the demand for strategic outsourcing, creating a distinct class of contract development and manufacturing services suppliers.

Viral Safety Of Biologics: What's Changing With The ICH Q5A Revision?

ICH Q5A is currently being revised to address recent scientific advancements. We'll discuss the expected changes and potential impact on viral safety strategies.

Tech Transfer In Sterile Injectables: 3 Phases Of Success

Explore the three phases of sterile injectable project tech transfer, including how to bridge information gaps and facilitate successful regulatory filing at this fundamental stage of drug development.

News Headlines
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.